Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Buzzelet Development And Technologies Ltd. currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 3 actions are distributed across 3 distinct examiners and 3 distinct art units. This one-to-one ratio between pending actions and examiners indicates that each matter is being handled by a different individual, requiring the company to manage multiple examiner relationships simultaneously.
The busiest examiner for the portfolio is LI, CHANGQING, who is responsible for 1 pending office action. Because there are 3 distinct examiners for 3 pending actions, no single examiner holds a majority of the workload. This lack of concentration means the company must navigate the specific preferences of 3 different examiners without a single dominant point of contact at the patent office.
The presence of 3 distinct art units further suggests that the company's biotechnology innovations are spread across several different technical classifications. With 3 pending office actions distributed in this manner, practitioners should prepare for varied examination styles. The prosecution strategy must be adaptable to the specific requirements and historical trends of 3 distinct art units to ensure success across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LI, CHANGQING | 1 | 29.6% | +33.1% |
| NEAGU, IRINA | 1 | 46.8% | +57.2% |
| WARD, PAUL V | 1 | 83.2% | -12.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18126443 | CANNABIS COMPOSITIONS AND INDUSTRIAL METHODS FOR PRODUCTION THEREOF | WARD, PAUL V | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18845450 | CANNABINOID-CONTAINING COMPOSITIONS AND USES THEREOF IN FOOD | LI, CHANGQING | — |
| 18266618 | COMPOSITIONS COMPRISING CANNABINOID ACID ESTERS | NEAGU, IRINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18845450 | CANNABINOID-CONTAINING COMPOSITIONS AND USES THEREOF IN FOOD | LI, CHANGQING | — |
| 18266618 | COMPOSITIONS COMPRISING CANNABINOID ACID ESTERS | NEAGU, IRINA | — |
| Art Unit | Apps |
|---|---|
| 1791 | 1 |
| 1629 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18845450 | CANNABINOID-CONTAINING COMPOSITIONS AND USES THEREOF IN FOOD | LI, CHANGQING | 1791 | §103 | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18266618 | COMPOSITIONS COMPRISING CANNABINOID ACID ESTERS | NEAGU, IRINA | 1629 | §102§103 | Non-Final OA | — | Pending | Jun 12, 2023 |
| 18126443 | CANNABIS COMPOSITIONS AND INDUSTRIAL METHODS FOR PRODUCTION THEREOF | WARD, PAUL V | 1622 | §103 | Non-Final OA | — | Pending | Mar 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBuzzelet Development And Technologies Ltd. has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.
Changqing Li has the most, with 1 of Buzzelet Development And Technologies Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.